Back
Repligen Stock Predictions
Sponsored
RGEN
Sponsored
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
30
RGEN
Repligen
Last Price:
124.90
Seasonality Move:
7.3%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.Repligen Stock Forecast
- Over the next 52 weeks, Repligen has on average historically risen by 22% based on the past 38 years of stock performance.
- Repligen has risen higher in 21 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.26%
-
Is Repligen Stock Undervalued?
The current Repligen [RGEN] share price is $124.73. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal. - RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Repligen Stock Go Up Next Year?
- Over the next 52 weeks, Repligen has on average historically risen by 22% based on the past 38 years of stock performance.
Repligen Stock Rating
Sell
30
Repligen (RGEN)
is a Sell
Is Repligen overpriced?
- Repligen has risen higher in 21 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.26%
Repligen Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
repligen.com
52-Week Data
52-Week High:
211.13
52-Week Low:
113.50
Prediction Charts
Market Cap:
6.99B
Price in USD:
124.73
Volume:
1.91M
Beta:
0.97
Technical Analysis
SMA50:
141.19
SMA100:
141.82
SMA200:
157.58
52-Wk Change:
-20.01%
Stock Predictions
-
Is Repligen stock public?
Yes, Repligen is a publicly traded company. -
What is the Repligen stock quote today?
The Repligen stock price is 124.73 USD today. -
How to buy Repligen stock online?
You can buy Repligen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-29 | 135.89 | 134.90 | 138.96 | 133.58 |
Oct-30 | 133.56 | 136.41 | 139.25 | 133.56 |
Oct-31 | 135.08 | 134.24 | 137.50 | 134.12 |
Nov-1 | 134.27 | 138.61 | 138.79 | 134.27 |
Nov-4 | 138.64 | 139.67 | 140.74 | 136.41 |
Nov-5 | 138.32 | 145.95 | 146.03 | 138.32 |
Nov-6 | 150.10 | 145.93 | 150.78 | 141.00 |
Nov-7 | 145.26 | 143.88 | 146.35 | 142.95 |
Nov-8 | 143.04 | 140.64 | 143.27 | 140.00 |
Nov-11 | 140.80 | 139.51 | 141.83 | 137.27 |
Nov-12 | 147.50 | 148.59 | 154.48 | 145.00 |
Nov-13 | 144.96 | 150.43 | 154.32 | 143.95 |
Nov-14 | 148.58 | 142.43 | 149.88 | 142.08 |
Nov-15 | 140.87 | 124.73 | 141.17 | 121.52 |
Repligen Earnings
Repligen Earnings Report: Per Share Repligen Earnings Q1 Q2 Q3 and Q4 last year and next year.
Repligen Forecast Revenue Growth
Repligen Stock Analysis: Historical quarterly revenues per share for Repligen and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.
* Repligen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.